 TUCSON, Ariz., Dec. 21, 2022 GLOBE NEWSWIRE HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced the pricing of a public offering of an aggregate of 1,290,322 shares of its common stock or pre-funded warrants in lieu ... The post HTG Molecular Diagnostics Announces Pricing of a 10 Million Public Offering appeared first on Fore... 